Items where authors include "Vital, EM"

Article

Carter, LM orcid.org/0000-0002-8724-5937, Alase, A, Wigston, Z et al. (10 more authors) (2023) Gene expression and autoantibody analysis reveals distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus. Arthritis & Rheumatology, 75 (5). pp. 697-710. ISSN 2326-5191

Carter, LM orcid.org/0000-0002-8724-5937, Wigston, Z, Laws, P et al. (1 more author) (2023) Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers. British Journal of Dermatology. ISSN 0007-0963

Md Yusof, MY orcid.org/0000-0003-3131-9121, Arnold, J, Saleem, B et al. (5 more authors) (2023) Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. The Lancet Rheumatology, 5 (2). e88-e98. ISSN 2665-9913

Robinson, JI orcid.org/0000-0001-5425-7520, Md Yusof, MY orcid.org/0000-0003-3131-9121, Davies, V et al. (20 more authors) (2022) Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. eBioMedicine, 86. 104343. ISSN 2352-3964

Pepple, S, Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755 et al. (5 more authors) (2022) Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR Open Rheumatology, 4 (8). pp. 689-699. ISSN 2578-5745

Carter, LM, Alase, A, Wigston, Z et al. (8 more authors) (2022) OA09 Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE. Rheumatology, 61 (Supplement_1). i4-i5. ISSN 1462-0324

Carter, LM orcid.org/0000-0002-8724-5937, McGonagle, D, Vital, EM orcid.org/0000-0003-1637-4755 et al. (1 more author) (2022) Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective. Journal of Investigative Dermatology, 142 (3). pp. 944-950. ISSN 0022-202X

Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755, Dass, S et al. (5 more authors) (2022) A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology, 12. 803175. ISSN 1664-3224

Md Yusof, MY orcid.org/0000-0003-3131-9121 and Vital, EM orcid.org/0000-0003-1637-4755 (2022) Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization. Rheumatology Advances in Practice, 6 (1). rkab106. ISSN 2514-1775

Mahmoud, K, Zayat, AS, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (12 more authors) (2021) Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology, 60 (11). pp. 5194-5204. ISSN 1462-0324

Ponchel, F orcid.org/0000-0002-3969-7701, Churchman, S, El-Jawhari, JJ et al. (8 more authors) (2021) Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium. Clinical and Experimental Rheumatology, 39 (2). ISSN 0392-856X

Psarras, A, Antanaviciute, A, Alase, A et al. (5 more authors) (2021) TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation. The Journal of Immunology. ji1901358. ISSN 0022-1767

Hassan, SU, Md Yusof, MY, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab. Frontiers in Medicine, 7. 498. ISSN 2296-858X

Yusof, MYM, Vital, EM orcid.org/0000-0003-1637-4755, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2020) Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY. Arthritis & Rheumatology, 72 (7). pp. 1231-1233. ISSN 2326-5191

Marzo-Ortega, H, Tan, AL orcid.org/0000-0002-9158-7243, Bissell, L-A et al. (4 more authors) (2020) Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic. The Lancet Rheumatology, 2 (7). E386-E387. ISSN 2665-9913

Lamana, A, Villares, R, Seoane, IV et al. (14 more authors) (2020) Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity. Frontiers in Immunology, 11. 1336. ISSN 1664-3224

Garcia-Montoya, L, Villota-Eraso, C, Yusof, MYM et al. (2 more authors) (2020) Lessons for rituximab therapy in patients with rheumatoid arthritis. The Lancet Rheumatology. ISSN 2665-9913

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A et al. (11 more authors) (2020) B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 72 (5). pp. 769-779. ISSN 2326-5191

Yusof, MYM, Iqbal, K, Darby, M et al. (6 more authors) (2020) Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. Rheumatology. ISSN 1462-0324

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, DM et al. (7 more authors) (2019) Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 71 (11). pp. 1812-1823. ISSN 2326-5191

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Edward, S et al. (6 more authors) (2019) Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus. Lupus, 28 (11). pp. 1320-1328. ISSN 0961-2033

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 71 (9). pp. 1400-1412. ISSN 2326-5191

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases, 78 (9). pp. 1151-1159. ISSN 0003-4967

Mahmoud, K, Zayat, AS, Yusof, Y et al. (4 more authors) (2019) Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Rheumatology, 58 (8). key422. pp. 1353-1360. ISSN 1462-0324

Shalbaf, M, Alase, AA, Berekmeri, A et al. (8 more authors) (2019) Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature. Lupus Science and Medicine, 6 (1). e000328. ISSN 2053-8790

Stevens, MJ, Walker-Bone, K, Culliford, DJ et al. (8 more authors) (2019) Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national survey. Journal of Foot and Ankle Research, 12. ARTN 26.

Zayat, AS, Mahmoud, K, Yusof, MYM et al. (8 more authors) (2019) Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology, 58 (2). key277. pp. 304-312. ISSN 1462-0324

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (9 more authors) (2018) Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Annals of the Rheumatic Diseases, 77 (10). pp. 1432-1439. ISSN 0003-4967

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2018) Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology, 57 (3). pp. 470-479. ISSN 1462-0324

Romão, VC, Vital, EM orcid.org/0000-0003-1637-4755, Fonseca, JE et al. (1 more author) (2017) Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? Arthritis Research & Therapy, 19 (1). 239. ISSN 1478-6354

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (4 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 76 (11). pp. 1829-1836. ISSN 0003-4967

Glinatsi, D, Bird, P, Gandjbakhch, F et al. (6 more authors) (2017) Development and Validation of the OMERACT Rheumatoid Arthritis Magnetic Resonance Tenosynovitis Scoring System in a Multireader Exercise. Journal of Rheumatology, 44 (11). pp. 1688-1693. ISSN 0315-162X

Psarras, A, Emery, P and Vital, EM (2017) Type I Interferon-Mediated Autoimmune Diseases: pathogenesis, diagnosis, and targeted therapy. Rheumatology, 56 (10). pp. 1662-1675. ISSN 1462-0324

Mahmoud, K, Zayat, A and Vital, EM orcid.org/0000-0003-1637-4755 (2017) Musculoskeletal manifestations of systemic lupus erythmatosus. Current Opinion in Rheumatology, 29 (5). pp. 486-492. ISSN 1040-8711

Md Yusof, MY orcid.org/0000-0003-3131-9121, Kabia, A, Darby, M et al. (5 more authors) (2017) Effect of rituximab on the progression of rheumatoid arthritis–related interstitial lung disease: 10 years’ experience at a single centre. Rheumatology, 56 (8). pp. 1348-1357. ISSN 1462-0324

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) Corrigendum: The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). p. 1049. ISSN 1462-0324

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). pp. 1041-1043. ISSN 1462-0324

Cherry, L, Alcacer-Pitarch, B, Hopkinson, N et al. (5 more authors) (2017) The prevalence of self-reported lower limb and foot health problems experienced by participants with systemic lupus erythematosus: Results of a UK national survey. Lupus, 26 (4). pp. 410-416. ISSN 0961-2033

Sellam, J, Rivière, E, Courties, A et al. (11 more authors) (2017) Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research and Therapy, 19. 11. ISSN 1478-6354

Sellam, J, Riviere, E, Courties, A et al. (11 more authors) (2016) Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy, 18. 294. ISSN 1478-6354

Care, MA, Stephenson, SJ, Barnes, NA et al. (7 more authors) (2016) Network analysis identifies proinflammatory plasma cell polarization for secretion of ISG15 in human autoimmunity. Journal of Immunology, 197 (4). pp. 1447-1459. ISSN 0022-1767

Zayat, AS, Md Yusof, MY, Wakefield, RJ et al. (3 more authors) (2016) The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review. Rheumatology, 55 (3). pp. 485-494. ISSN 1462-0324

Alase, AA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Vital, EM orcid.org/0000-0003-1637-4755 et al. (3 more authors) (2015) IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism. Journal of Investigative Dermatology, 135 (12). pp. 2935-2943. ISSN 0022-202X

Md Yusof, MY, Vital, EM and Buch, MH (2015) B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use. Current Rheumatology Reports, 17 (10). 65. ISSN 1523-3774

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

Vital, EM, Dass, S, Buch, MH orcid.org/0000-0002-8962-5642 et al. (2 more authors) (2015) An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial. Annals of the Rheumatic Diseases, 74 (6). pp. 1195-1201. ISSN 0003-4967

Vital, EM, Md Yusof, MY and Emery, P (2014) Choosing the right rituximab dose for the right patient: Comment on the article by Bredemeier et al. Arthritis Care and Research, 66 (10). 1591 - 1593. ISSN 2151-464X

Md Yusof, MY, Vital, EM and Emery, P (2014) Biologics in systemic lupus erythematosus: current options and future perspectives. British Journal of Hospital Medicine, 75 (8). 440 - 447. ISSN 1750-8460

Das, S, Vital, EM, Horton, S et al. (6 more authors) (2014) Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5). 909 - 912. ISSN 0003-4967

Arumugakani, G, Vital, EM, Md Yusof, MY et al. (2 more authors) (2014) Response to: 'Which B-cell subset should we target in lupus?' By Ferraccioli and Houssiau. Annals of the Rheumatic Diseases, 73 (4). e20. ISSN 0003-4967

Ponchel, F, Burska, AN and Vital, EM (2014) Pharmacogenomics in rheumatoid arthritis: how close are we to the clinic? Pharmacogenomics, 15 (10). 1275 - 1279. ISSN 1462-2416

Ponchel, F, Goëb, V, Parmar, R et al. (9 more authors) (2013) An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases. ISSN 0003-4967

Md Yusof, MY, Vital, EM and Emery, P (2013) B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: Current progress. Expert Review of Clinical Immunology, 9 (8). 761 - 772. ISSN 1744-666X

Buch, MH orcid.org/0000-0002-8962-5642, Vital, EM orcid.org/0000-0003-1637-4755 and Emery, P orcid.org/0000-0002-7429-8482 (2008) Abatacept in the treatment of rheumatoid arthritis. Arthritis Research and Therapy, 10 Suppl 1 (S5). S5-. ISSN 1478-6354

Conference or Workshop Item

Giollo, A, Gandrala, S, Vojinovic, T et al. (5 more authors) (2018) THU0136 Major cardiovascular events in 434 rheumatoid arthritispatients treated with rituximab from a single-centre. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

Proceedings Paper

Yusof, YM, Arnold, J, Saleem, B et al. (5 more authors) (2022) Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 1559-1560.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2017) Laser doppler imaging: an objective outcome measure for assessment of cutaneous lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 1019-1020.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 869.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (6 more authors) (2017) Prediction of connective tissue disease in an at-risk cohort using a novel interferon stimulated gene expression score. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 91.

Roberts, C, Guillard, G, Bowes, MA et al. (12 more authors) (2017) Quantitative 3D imaging of tenosynovitis and bone marrow edema by DCE-MRI is a sensitive measure of response to therapy in rheumatoid arthritis. In: Annals of the Rheumatic Diseases. EULAR 2017, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 1010.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, D et al. (5 more authors) (2017) Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 987.

Mahmoud, K, Zayat, A, Edwards, CJ et al. (5 more authors) (2016) An Evaluation of Clinical Outcome Measures for Musculoskeletal Lupus Using Ultrasound as A Gold Standard: Table 1. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ PUblishing Group , p. 556.

Zayat, AS, Mahmoud, K, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (4 more authors) (2016) A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. In: Annals of the Rheumatic Diseases. Annual European Conference of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 549.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (4 more authors) (2016) Incomplete and Systemic Lupus Erythematosus Reveal A Different Pattern of Interferon-Stimulated Genes Up-Regulation. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , pp. 285-286.

Md Yusof, MY, Hensor, EM, Das, S et al. (3 more authors) (2016) Risk Factors for Severe Infection and Outcome of Secondary Hypogammaglobulinaemia in Patients with Autoimmune Rheumatic Diseases Treated with Rituximab: Preliminary Results from 400 Patients at A Single Centre. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 845.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, Rawstron, A et al. (2 more authors) (2016) Validation of Highly Sensitive Flow Cytometry as A Biomarker for Rituximab in Sle: A Rationale for More Intensive Treatment To Improve Clinical Outcomes. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 296.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.